Physician Resources
2 FILES

Patient Resources
2 FILES

Patient Resources
Indications & Usage

    INDICATIONS AND USAGE

    PHEXXI is a combination of lactic acid (1.8%), citric acid (1%), and potassium bitartrate (0.4%) indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.

    LIMITATIONS OF USE

    PHEXXI is not effective for the prevention of pregnancy when administered after intercourse.

    This information does not include all that is needed to use PHEXXI™ safely and effectively. See full prescribing information for PHEXXI for more information.


    Please see full Prescribing Information for Phexxi.

 

Dosage & Administration

DOSAGE AND ADMINISTRATION

·    Administer one (1) pre-filled single-dose applicator of PHEXXI (5 grams) vaginally immediately before (or up to one hour before) each episode of vaginal intercourse

·    May use during any part of the menstrual cycle

 

This information does not include all that is needed to use PHEXXI™ safely and effectively. See full prescribing information for PHEXXI for more information.


Please see full Prescribing Information for Phexxi.

Warnings & Precautions


WARNINGS AND PRECAUTIONS


     ·         Cystitis and Pyelonephritis: Avoid use in women with a history of recurrent UTI or urinary tract abnormalities

 

This information does not include all that is needed to use PHEXXI™ safely and effectively. See full prescribing information for PHEXXI for more information.


Please see full Prescribing Information for Phexxi.

Adverse Reactions

ADVERSE REACTIONS


Most common adverse reactions (≥2%) were vulvovaginal burning sensation, vulvovaginal pruritus, vulvovaginal mycotic infection, urinary tract infection, vulvovaginal discomfort, bacterial vaginosis, vaginal discharge, genital discomfort, dysuria, and vulvovaginal pain.

 

To report SUSPECTED ADVERSE REACTIONS, contact Evofem at toll-free phone 1-833-EVFMBIO or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.


This information does not include all that is needed to use PHEXXI™ safely and effectively. See full prescribing information for PHEXXI for more information.


Please see full Prescribing Information for Phexxi.


Trademarks are owned by Evofem Biosciences.
This website is funded and developed by Evofem Biosciences.
This site is intended for United States healthcare professionals only.
© 2020 Evofem Biosciences. • EVFM-US-000703 • September 2020




Please see full Prescribing Information for Phexxi.

Please scroll below for Important Safety Information

 



IMPORTANT SAFETY INFORMATION


INDICATIONS AND USAGE

PHEXXI is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.

 

LIMITATIONS OF USE

PHEXXI is not effective for the prevention of pregnancy when administered after intercourse.


WARNINGS AND PRECAUTIONS

Few cases (0.36%) of adverse reactions of cystitis, pyelonephritis and other upper urinary tract infection (UTI) have been reported in PHEXXI clinical studies. Of these, one case of pyelonephritis was considered serious and required hospitalization.  Avoid use of PHEXXI in females of reproductive potential with history of recurrent urinary tract infection or urinary tract abnormalities.

 

ADVERSE REACTIONS

Most common adverse reactions were vulvovaginal burning sensation, vulvovaginal pruritus, vulvovaginal mycotic infection, urinary tract infection, vulvovaginal discomfort, bacterial vaginosis, vaginal discharge, genital discomfort, dysuria, and vulvovaginal pain.

 

Patients should be counseled on the following:

  • To contact and consult with their healthcare provider for severe or prolonged genital irritation or experiencing urinary tract symptoms.
  • To discontinue PHEXXI if they develop a local hypersensitivity reaction.
  • That  PHEXXI  does not protect against HIV infection or other sexually transmitted infections.

 

To report SUSPECTED ADVERSE REACTIONS, contact Evofem at toll-free phone 1-833-EVFMBIO or you may contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

 


Please see full Prescribing Information for PHEXXI.